Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Medtronic PLC MDT

Healthcare Medical Devices
Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic... see more

Recent & Breaking News (NYSE:MDT)

Medtronic announces FDA approval of newest-generation Evolut TAVR system for treatment of symptomatic severe aortic stenosis

PR Newswire March 27, 2024

U.S. Patent Office rejects Axonics' latest challenge to Medtronic patents

PR Newswire March 21, 2024

Orchestra BioMed Demonstrates Strength of Cardiovascular Pipeline with Virtue® SAB and AVIM Therapy Presentations at CRT 2024 Annual Meeting

GlobeNewswire March 13, 2024

New real-world data shows MiniMed(TM) 780G system sustains strong global performance, exceeding international targets for diabetes management

PR Newswire March 9, 2024

Medtronic announces cash dividend for fourth quarter of fiscal year 2024

PR Newswire March 7, 2024

Medtronic EVP & CFO Karen Parkhill to participate in the Barclays healthcare conference

PR Newswire March 5, 2024

Medtronic Once Again Named One of the World's Most Ethical Companies

Accesswire March 4, 2024

Medtronic files ITC action against Axonics to stop unauthorized use of Medtronic innovations

PR Newswire February 29, 2024

Orchestra BioMed Presents New Data Showing Sustained Clinically Meaningful Reduction in 24-Hour Ambulatory Systolic Blood Pressure in Hypertensive Pacemaker Patients Treated with AVIM Therapy for Over 3 Years

GlobeNewswire February 26, 2024

Upfront Tuition Coverage Is a Game-Changer for Medtronic Employees

Accesswire February 21, 2024

Medtronic reports third quarter fiscal 2024 financial results

PR Newswire February 20, 2024

Medical Technology Stocks to Keep On The Radar

TheNewsWire February 20, 2024

Grounding in Healing To Navigate the DEI Landscape in 2024

Accesswire February 7, 2024

Medtronic: Green Flags To Look For in ID&E Reporting

Accesswire February 6, 2024

Medtronic to announce financial results for its third quarter of fiscal year 2024

PR Newswire February 6, 2024

Medtronic Named One of America's Most JUST Companies

Accesswire February 5, 2024

Medtronic: Here Comes the Sun - 3 Things To Know About Our Solar Footprint

Accesswire January 22, 2024

Medtronic LABS President Ruchika Singhal Named "Corporate Social Innovator of the Year" by Schwab Foundation

Accesswire January 16, 2024

FDA approves Medtronic Percept(TM) RC neurostimulator with exclusive BrainSense(TM) technology

PR Newswire January 8, 2024

Orchestra BioMed Announces Initiation of BACKBEAT Pivotal Study of AVIM Therapy in Hypertensive Pacemaker Patients

GlobeNewswire January 8, 2024